Learn about our solutions for accelerating vaccine development – from Gene Synthesis to Vaccine Expression and Purification.

Presenters:

Title: Enhanced, rapid target identification by NGS for vaccine development
Speaker: Cris Kinross, Global Market Development
Title: From Synthetic Gene to Vaccine: Confidence with GeneArt Gene Synthesis Services
Speaker: Julie Robinson, Sr Product Manager
Title: Harnessing the Power of the Expi Protein Expression Systems in Vaccine Development
Speaker: Roland Leathers, Senior Manager Strategic Alliances, EMEA & AP
Title: Critical raw material for mRNA-based vaccine development
Speaker: Andrius Kočevas, Product Manager
Title: Invitrogen™ QuantiGene multiplex gene expression assays: A more reliable and efficient method for the evaluation of vaccine quality control and safety
Speaker: Stefan Jellbauer, PhD, Product Manager (QuantiGene gene expression assays)
 

* Required field

*
 PART 1 - Enhanced, rapid target identification by NGS for vaccine development
 PART 2 – From Synthetic Gene to Vaccine: Confidence with Gene Synthesis Services
 PART 3 – Harnessing the Power of Protein Expression Systems in Vaccine Development
 PART 4 – Critical Raw Material for mRNA-based Vaccine Development
 PART 5 – Multiplex Gene Expression Assays: A Reliable and Efficient Method for the Evaluation of Vaccine Quality Control and Safety
*
*
*
*
*

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.